| Analysis | Metabolite Name | Measured Value | Units | Model | Intervention |
|---|---|---|---|---|---|
| Reversed phase UNSPECIFIED ION MODE | Sphingosine | 0.00010 | peak area | Wild type | Saline |
| Reversed phase UNSPECIFIED ION MODE | Sphingosine | 0.00011 | peak area | Alzheimer’s disease model | B. breve MCC1274 |
| Reversed phase UNSPECIFIED ION MODE | Sphingosine | 0.00012 | peak area | Wild type | B. breve MCC1274 |
| Reversed phase UNSPECIFIED ION MODE | Sphingosine | 0.00012 | peak area | Wild type | Saline |
| Reversed phase UNSPECIFIED ION MODE | Sphingosine | 0.00013 | peak area | Alzheimer’s disease model | Saline |
| Reversed phase UNSPECIFIED ION MODE | Sphingosine | 0.00013 | peak area | Wild type | Saline |
| Reversed phase UNSPECIFIED ION MODE | Sphingosine | 0.00014 | peak area | Alzheimer’s disease model | B. breve MCC1274 |
| Reversed phase UNSPECIFIED ION MODE | Sphingosine | 0.00014 | peak area | Alzheimer’s disease model | Saline |
| Reversed phase UNSPECIFIED ION MODE | Sphingosine | 0.00015 | peak area | Alzheimer’s disease model | Saline |
| Reversed phase UNSPECIFIED ION MODE | Sphingosine | 0.00016 | peak area | Wild type | B. breve MCC1274 |
| Reversed phase UNSPECIFIED ION MODE | Sphingosine | 0.00016 | peak area | Wild type | Saline |
| Reversed phase UNSPECIFIED ION MODE | Sphingosine | 0.00017 | peak area | Alzheimer’s disease model | B. breve MCC1274 |
| Reversed phase UNSPECIFIED ION MODE | Sphingosine | 0.00021 | peak area | Alzheimer’s disease model | B. breve MCC1274 |
| Reversed phase UNSPECIFIED ION MODE | Sphingosine | 0.00025 | peak area | Wild type | B. breve MCC1274 |
| Reversed phase UNSPECIFIED ION MODE | Sphingosine | peak area | Alzheimer’s disease model | Saline | |
| Reversed phase UNSPECIFIED ION MODE | Sphingosine | peak area | Wild type | B. breve MCC1274 |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|